{"id":"https://openalex.org/W4404751925","doi":null,"title":"Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-\u03b2/Smad2/3 signaling pathway","display_name":"Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-\u03b2/Smad2/3 signaling pathway","publication_year":2019,"publication_date":"2019-05-01","ids":{"openalex":"https://openalex.org/W4404751925"},"language":"en","primary_location":{"id":"pmh:oai:doaj.org/article:f304980699614eb5ab40c6304a25ab34","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/f304980699614eb5ab40c6304a25ab34","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"OncoTargets and Therapy, Vol Volume 12, Pp 3893-3903 (2019)","raw_type":"article"},"volume":null,"type":"article","indexed_in":["doaj"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004857861","display_name":"Jingjing Yin","orcid":"https://orcid.org/0000-0003-4843-613X","observed_orcids":["https://orcid.org/0000-0003-4843-613X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yin J","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100403181","display_name":"Lin Wang","orcid":"https://orcid.org/0000-0002-6449-4930","observed_orcids":["https://orcid.org/0000-0002-6449-4930","https://orcid.org/0009-0007-0968-7610"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wang L","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100364925","display_name":"Yi Wang","orcid":"https://orcid.org/0000-0002-2067-5465","observed_orcids":["https://orcid.org/0000-0002-2067-5465","https://orcid.org/0000-0001-8622-3480"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wang Y","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Shen H","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shen H","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006211649","display_name":"Xinan Wang","orcid":"https://orcid.org/0000-0001-5236-1105","observed_orcids":["https://orcid.org/0000-0001-5236-1105"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wang X","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5055830554","display_name":"Lina Wu","orcid":"https://orcid.org/0000-0001-8640-6279","observed_orcids":["https://orcid.org/0000-0001-8640-6279"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wu L","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.23835744,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11319","display_name":"Curcumin's Biomedical Applications","score":0.7782999873161316,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11319","display_name":"Curcumin's Biomedical Applications","score":0.7782999873161316,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.048500001430511475,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.021400000900030136,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/curcumin","display_name":"curcumin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/oxaliplatin-resistance","display_name":"oxaliplatin resistance","score":0.9990000128746033},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.9810000061988831},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.777999997138977},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8690000176429749},{"id":"https://openalex.org/keywords/cell-invasion","display_name":"cell invasion","score":0.7360000014305115},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6909999847412109},{"id":"https://openalex.org/keywords/hct116-cells","display_name":"HCT116 cells","score":0.8539999723434448},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.9020000100135803},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.9800000190734863},{"id":"https://openalex.org/keywords/nf-kappab-p65-phosphorylation","display_name":"p65 phosphorylation","score":0.7979999780654907},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.5429999828338623},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.6890000104904175}],"concepts":[{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.7777957320213318},{"id":"https://openalex.org/C2778250585","wikidata":"https://www.wikidata.org/wiki/Q312266","display_name":"Curcumin","level":2,"score":0.7122132182121277},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6613650321960449},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.5163594484329224},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5121660232543945},{"id":"https://openalex.org/C2778229498","wikidata":"https://www.wikidata.org/wiki/Q24785672","display_name":"Transforming growth factor beta","level":3,"score":0.4681318998336792},{"id":"https://openalex.org/C2776174256","wikidata":"https://www.wikidata.org/wiki/Q830842","display_name":"BETA (programming language)","level":2,"score":0.4561426639556885},{"id":"https://openalex.org/C111001777","wikidata":"https://www.wikidata.org/wiki/Q3562192","display_name":"TGF beta signaling pathway","level":3,"score":0.4494115114212036},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.413334459066391},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38257724046707153},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3784712255001068},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3520318865776062},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3301845192909241},{"id":"https://openalex.org/C118131993","wikidata":"https://www.wikidata.org/wiki/Q423671","display_name":"Transforming growth factor","level":2,"score":0.314574658870697},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.31388378143310547},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1247304379940033},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.054661065340042114},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:doaj.org/article:f304980699614eb5ab40c6304a25ab34","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/f304980699614eb5ab40c6304a25ab34","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"OncoTargets and Therapy, Vol Volume 12, Pp 3893-3903 (2019)","raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.7699999809265137,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2564614492","https://openalex.org/W2341020835","https://openalex.org/W2066673453","https://openalex.org/W3087082563","https://openalex.org/W2615920181","https://openalex.org/W1970564305","https://openalex.org/W2736381666","https://openalex.org/W2765743265","https://openalex.org/W4388460801","https://openalex.org/W3007064358"],"abstract_inverted_index":{"Jiahuan":[0],"Yin,1,*":[1],"Li":[2],"Wang,2,*":[3],"Yong":[4],"Wang,1":[5,9],"Hailong":[6],"Shen,1":[7],"Xiaojie":[8],"Lei":[10],"Wu11Department":[11],"of":[12,22,25,36,54,115,131,163,171,185,207,223,231,240],"General":[13],"Surgery,":[14],"Shanghai":[15,18,29,32],"Luodian":[16,30],"Hospital,":[17,31],"201908,":[19,33],"People\u2019s":[20,34],"Republic":[21,35],"China;":[23],"2Department":[24],"Gynaecology":[26],"and":[27,141,168,178,205,225,273],"Obstetrics,":[28],"China*These":[37],"authors":[38],"contributed":[39],"equally":[40],"to":[41,51,111,159],"this":[42],"workBackground:":[43],"Oxaliplatin":[44],"(OXA)":[45],"resistance":[46,98,119,213,253,264],"is":[47,62],"a":[48,193],"main":[49],"obstacle":[50],"the":[52,113,161,169,182,217,221,229],"chemotherapy":[53],"colorectal":[55,276],"cancer":[56],"(CRC).":[57],"Epithelial-mesenchymal":[58],"transition":[59],"(EMT),":[60],"which":[61],"mainly":[63],"regulated":[64,85],"by":[65,138,150,176],"TGF-\u03b2/Smad":[66,103,172,283],"signaling":[67,173,242,270,284],"pathway,":[68],"has":[69],"gradually":[70],"been":[71],"recognized":[72],"as":[73],"an":[74,109],"important":[75],"mechanism":[76],"for":[77],"tumor":[78],"chemoresistance.":[79],"Studies":[80],"have":[81],"shown":[82],"that":[83,259],"curcumin":[84,94,116,132,164,186,210,235,249,260],"EMT":[86,105,237],"processes":[87],"in":[88,99,120,190,214,245,254,265,271,274],"many":[89],"human":[90],"cancers.":[91],"However,":[92],"whether":[93],"could":[95,250,261],"regulate":[96],"OXA":[97,118,208,212,252,263],"CRC":[100,194,266],"through":[101,267],"modulating":[102],"signaling-mediated":[104],"remains":[106],"unclear.Methods:":[107],"In":[108,153,233],"attempt":[110],"investigate":[112],"effect":[114,130,162],"on":[117,133,165],"CRC,":[121],"OXA-resistant":[122,198],"cell":[123,134,166,199],"line":[124,200],"HCT116/OXA":[125,201],"was":[126,136,148,157,174,187,202],"established":[127],"firstly.":[128],"The":[129,197],"proliferation":[135],"evaluated":[137,149],"MTT":[139],"assay":[140,156],"Ki67":[142],"immunofluorescence":[143,177],"staining,":[144],"respectively.":[145],"Cell":[146],"apoptosis":[147],"flow":[151],"cytometry.":[152],"addition,":[154,234],"transwell":[155],"used":[158],"detect":[160],"invasion":[167],"activation":[170],"examined":[175,189],"Western":[179],"blot.":[180],"Moreover,":[181,244],"therapeutic":[183],"potential":[184],"further":[188],"vivo":[191,246],"using":[192],"animal":[195],"model.Results:":[196],"successfully":[203],"established,":[204],"combination":[206,218],"with":[209],"reduced":[211],"vitro.":[215],"Besides,":[216],"treatment":[219],"inhibited":[220,236],"expressions":[222],"p-p65":[224],"Bcl-2,":[226],"but":[227],"increased":[228],"level":[230],"active-caspase3.":[232],"via":[238],"regulation":[239],"TGF-\u03b2/Smad2/3":[241],"pathway.":[243],"study":[247,257],"confirmed":[248],"reverse":[251],"CRC.Conclusion:":[255],"Our":[256],"indicated":[258],"reserve":[262],"dampening":[268],"TGF-\u03b2/Smads":[269],"vitro":[272],"vivo.Keywords:":[275],"cancer,":[277],"oxaliplatin":[278],"resistance,":[279],"curcumin,":[280],"epithelial-mesenchymal":[281],"transition,":[282],"pathway":[285]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2024-11-27T00:00:00"}